Myasthenia Gravis

TL;DR. Myasthenia gravis is an uncommon neuromuscular disorder in dogs and cats that causes progressive muscle weakness during exercise. It can be inherited or autoimmune, often leading to swallowing difficulties and a high risk of life-threatening aspiration pneumonia.

Generalized muscle weakness that worsens with exercise is a classic sign of myasthenia gravis.

What is it?

Myasthenia gravis (MG) is a complex disorder of the neuromuscular junction—the specialized site where nerves communicate with muscles. In a healthy pet, when the brain sends a signal to move a muscle, nerves release a chemical messenger called acetylcholine (ACh). This chemical travels across a tiny gap and binds to specific receptors on the muscle surface, triggering a contraction.

In pets with myasthenia gravis, this communication system breaks down. The muscles cannot receive the signals properly because there are not enough functioning acetylcholine receptors. This results in muscle weakness that characteristically worsens with exercise or repetitive movement but improves after a period of rest.

There are two distinct forms of this condition: congenital and acquired. Congenital myasthenia gravis is an inherited disorder where an animal is born with an abnormally low number of acetylcholine receptors. Acquired myasthenia gravis is an autoimmune disease where the pet's own immune system mistakenly produces antibodies that attack and destroy these vital receptors.

For pet owners, understanding this disease is critical because it does not just affect the limbs. It frequently impacts the muscles of the throat and esophagus (the tube connecting the mouth to the stomach). This can lead to severe swallowing difficulties and a condition called megaesophagus, which places pets at an extremely high risk of inhaling food or liquid into their lungs, causing life-threatening pneumonia.

Causes & risk factors

Acquired myasthenia gravis is caused by an immune system malfunction. Instead of protecting the body, the immune system produces autoantibodies that target the acetylcholine receptors. As a leading veterinary internal medicine reference explains:

"Antibodies bind to the receptors, reducing sensitivity of the postsynaptic membrane to ACh. Acquired MG affects dogs of all breeds and both genders. German Shepherd Dogs, Golden Retrievers, Labrador Retrievers, and Dachshunds are most commonly affected, but this may merely reflect the popularity of these breeds."

In addition to primary autoimmune disease, acquired myasthenia gravis can be triggered by or associated with other underlying medical conditions. These include:

• Thymoma: A tumor of the thymus gland (an organ in the chest involved in immune function).
• Other cancers: Various underlying tumors can trigger an abnormal immune response that leads to MG.
• Other immune-mediated disorders: Conditions like hypothyroidism (underactive thyroid) and hypoadrenocorticism (Addison's disease) sometimes occur alongside myasthenia gravis, as the body is prone to multiple autoimmune issues.

Congenital myasthenia gravis is entirely genetic and is not caused by an autoimmune attack. Affected puppies or kittens are born with a physical deficiency in their receptors, meaning their immune system is not involved in the destruction of the neuromuscular junction.

Signs to watch for

The symptoms of myasthenia gravis can vary widely depending on whether the disease is generalized (affecting the whole body) or focal (affecting only specific muscle groups like the throat and face).

• Appendicular muscle weakness (Cardinal): Weakness in the limbs is the hallmark sign. Your pet may start a walk normally but quickly become stiff, short-strided, or shaky, eventually lying down. After a brief rest, they may stand up and walk normally again, only for the cycle to repeat.
• Megaesophagus (Common): A dilated, weak esophagus that cannot push food down to the stomach.
• Regurgitation (Common): Unlike vomiting, which is an active process involving abdominal retching, regurgitation is the passive casting up of undigested food or water, often occurring suddenly and without warning.
• Aspiration pneumonia (Common): Caused by food or liquid accidentally entering the lungs due to swallowing weakness. Signs include coughing, fever, nasal discharge, and labored breathing.
• Excessive salivation (Common): Drooling caused by an inability to swallow saliva normally.
• Recumbency (Occasional): An inability to stand up or walk at all in severe cases.
• Dysphagia (Occasional): Difficulty physically chewing or swallowing food.
• Dysphonia (Occasional): A change in the sound of your pet's bark or meow, or a loss of voice.
• Facial muscle weakness (Occasional): Drooping of the lips, eyelids, or ears.
• Fatigable palpebral reflex (Occasional): If your vet gently taps the corner of your pet's eye, the blinking reflex will become weaker and weaker with each consecutive tap.
• Stiff, short-strided gait (Occasional): Walking as if on eggshells due to muscle fatigue.
• Passive ventroflexion of the head and neck (Occasional): A drooping neck posture where the pet cannot hold their head up. This is particularly common in cats.
• Persistently dilated pupils (Rare): A rare manifestation of autonomic nervous system involvement.

Megaesophagus, a widening of the food pipe, is a common and serious complication of myasthenia gravis.

How vets diagnose it

Diagnosing myasthenia gravis requires a systematic approach, as many other neurological and orthopedic conditions can cause weakness. Your vet will begin with a thorough physical and neurological examination, looking closely for signs of muscle fatigue and testing reflexes.

• Serum Acetylcholine Receptor (AChR) Antibody Titer: This is the gold-standard diagnostic test for the acquired form of the disease. It is a highly specific blood test that measures the concentration of antibodies directed against acetylcholine receptors. However, timing is critical. As a leading textbook notes:

  "Immunosuppressive doses of corticosteroids lower the antibody concentration and can interfere with testing. Because antibodies are not the cause of congenital MG, results of antibody testing will be negative."

• Edrophonium Response Testing (Tensilon Test): Your vet may administer an intravenous injection of edrophonium chloride, a short-acting drug that temporarily prevents the breakdown of acetylcholine. If your pet has myasthenia gravis, this sudden boost in acetylcholine often leads to a dramatic, immediate improvement in muscle strength lasting a few minutes. While highly suggestive, this test is not entirely foolproof and is usually paired with other diagnostics.

• Thoracic Radiographs (Chest X-rays): Chest X-rays are essential for every suspected case. They allow your vet to look for megaesophagus, evaluate the lungs for signs of aspiration pneumonia, and check the front of the chest cavity for a thymoma.

• Electrodiagnostic Testing (Repetitive Nerve Stimulation): In complex cases, or when congenital MG is suspected, a specialist may perform electrodiagnostics. This involves stimulating a nerve repeatedly and measuring the electrical response in the muscle; in MG patients, the muscle response rapidly declines.

• Intercostal Muscle Biopsy: This highly specialized procedure involves taking a small sample of muscle from between the ribs to physically count the number of acetylcholine receptors. It is typically reserved for confirming congenital myasthenia gravis.

Chest X-rays are vital to diagnose megaesophagus and monitor for aspiration pneumonia.

Treatment options

Treatment for myasthenia gravis is tailored to the individual pet, focusing on improving muscle strength, controlling the abnormal immune response, and providing intensive supportive care.

First-Line Therapies (Anticholinesterase Agents)

These medications are the cornerstone of long-term management. Drugs such as pyridostigmine or neostigmine work by blocking acetylcholinesterase, the enzyme responsible for breaking down acetylcholine. By keeping acetylcholine active in the neuromuscular junction for longer, these drugs help maximize the function of the remaining receptors. Your vet may also prescribe atropine to manage potential side effects of these medications, such as excessive drooling, abdominal cramping, or diarrhea.

Second-Line Therapies (Immunosuppressants)

If your pet has acquired myasthenia gravis and does not have active aspiration pneumonia, your vet may introduce medications to suppress the immune system and stop the production of destructive antibodies. These include glucocorticoids (such as prednisone), azathioprine, mycophenolate mofetil, or cyclosporine.

Note: Corticosteroids must be used with extreme caution. They can initially worsen muscle weakness and may increase the risk of your pet developing or failing to fight off aspiration pneumonia.

Supportive Care

Medical therapy alone is rarely enough. Supportive care is critical to keeping your pet stable, especially if they suffer from megaesophagus:

"Supportive care should include fluid and nutritional support and esophageal and gastric suctioning to prevent aspiration. Ventilatory support may be required in severely affected dogs."

To prevent regurgitation and aspiration, pets with megaesophagus must be fed highly digestible food in an upright position (often using a specially designed "Bailey Chair" for dogs, or by holding them upright). They must remain in this vertical position for 20 to 30 minutes after every meal to allow gravity to guide food into the stomach.

Prognosis

The prognosis for myasthenia gravis is highly variable and depends heavily on the presence of secondary complications. As the textbook literature warns:

"Severe aspiration pneumonia, persistent megaesophagus, acute fulminating MG, and the presence of a thymoma or another underlying neoplasm are all associated with a poor prognosis for recovery. Many affected dogs die of either acute fatal aspiration or euthanasia within 12 months of diagnosis."

However, the outlook is not entirely bleak. If aspiration pneumonia can be prevented or successfully managed, the response to medical therapy is often excellent. Furthermore, acquired myasthenia gravis is unique among autoimmune diseases because many affected dogs will experience spontaneous clinical and immunologic remission within 18 months of diagnosis, allowing them to eventually be successfully weaned off all medications.

For cats and exotic species, long-term prognosis data is more limited, and much of our clinical guidance is extrapolated from canine studies. Congenital cases carry a more guarded long-term prognosis because the physical lack of receptors cannot be cured, requiring lifelong medical management.

Prevention

Because acquired myasthenia gravis is an autoimmune disorder and congenital myasthenia gravis is an inherited genetic defect, there is no known way to prevent the disease from developing in an individual pet.

For breeds with a known genetic predisposition to the congenital form, prevention relies entirely on responsible breeding practices. Dogs that have produced puppies with congenital myasthenia gravis, as well as their close relatives, should not be used for breeding.

When to call your vet

Myasthenia gravis can change rapidly, and complications can become life-threatening in a matter of hours. You must contact your vet immediately if you notice any of the following red flags:

• Difficulty breathing, rapid breathing, or coughing (especially after eating or drinking, which indicates potential aspiration pneumonia).
• A sudden increase in the frequency or volume of regurgitation.
• Extreme lethargy, weakness, or an inability to stand up.
• A complete refusal to eat or drink.
• A sudden change in your pet's voice or an inability to swallow.

For specific breeds

Certain breeds carry a much higher risk of developing myasthenia gravis.

• Congenital (Inherited) Form: Jack Russell Terriers, English Springer Spaniels, and Smooth Fox Terriers have a proven autosomal recessive inheritance pattern for congenital MG. Puppies of these breeds usually begin showing signs of progressive weakness as early as 6 to 8 weeks of age.
• Acquired (Autoimmune) Form: Breeds with a suspected or documented increased risk relative to their popularity include German Shepherd Dogs, Golden Retrievers, Labrador Retrievers, Dachshunds (including Miniature Dachshunds), Giant Schnauzers, Australian Shepherds, German Shorthaired Pointers, Chihuahuas, and Akitas. Among cats, Abyssinians and Somalis are also suspected to have an increased risk of developing the acquired form.

Sources

• Internal Medicine, 5th Edition, page 1120.
• Internal Medicine, 5th Edition, page 1122.
• Internal Medicine, 5th Edition, page 1470.

My highlights & notes

New note